Abstract
The treatment of psoriatic arthritis (PsA) makes use of many agents. Most of them are used for the treatment of other forms of inflammatory arthritis or the management of cutaneous manifestations of psoriasis. Although a number of medications are effective in the treatment of both rheumatoid arthritis (RA) and PsA, trials involving some classes of biologic agents indicate that patients with RA and PsA may show different responses to certain drug classes. Treatment of the different elements of PsA includes coordinated interventions to address the major domains of the disease, including peripheral and axial arthritis, enthesitis, dactylitis, and skin and nail involvement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.